Sotera Health Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US83601L1026
USD
13.57
0.16 (1.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sotera Health Co.
Inspire Medical Systems, Inc.
Haemonetics Corp.
Masimo Corp.
Envista Holdings Corp.
Shockwave Medical, Inc.
Natera, Inc.
Bausch + Lomb Corp.
Lantheus Holdings, Inc.
QuidelOrtho Corp.
Dentsply Sirona, Inc.

Why is Sotera Health Co. ?

1
Healthy long term growth as Net Sales has grown by an annual rate of 7.68% and Operating profit at 10.70%
2
With a growth in Net Sales of 5.51%, the company declared Very Positive results in Sep 25
  • OPERATING CASH FLOW(Y) Highest at USD 267.94 MM
  • INTEREST COVERAGE RATIO(Q) Highest at 386.4
  • RAW MATERIAL COST(Y) Fallen by -12.51% (YoY)
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Sotera Health Co. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sotera Health Co. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sotera Health Co.
17.08%
0.29
43.02%
S&P 500
18.81%
1.04
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.68%
EBIT Growth (5y)
10.70%
EBIT to Interest (avg)
2.66
Debt to EBITDA (avg)
3.73
Net Debt to Equity (avg)
4.64
Sales to Capital Employed (avg)
0.40
Tax Ratio
71.81%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
14.37%
ROE (avg)
32.04%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
7.09
EV to EBIT
14.25
EV to EBITDA
10.47
EV to Capital Employed
2.40
EV to Sales
5.00
PEG Ratio
1.21
Dividend Yield
NA
ROCE (Latest)
16.81%
ROE (Latest)
24.53%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 267.94 MM

INTEREST COVERAGE RATIO(Q)

Highest at 386.4

RAW MATERIAL COST(Y)

Fallen by -12.51% (YoY

CASH AND EQV(HY)

Highest at USD 635.3 MM

DEBT-EQUITY RATIO (HY)

Lowest at 359.03 %

NET SALES(Q)

Highest at USD 311.31 MM

OPERATING PROFIT(Q)

Highest at USD 154.32 MM

OPERATING PROFIT MARGIN(Q)

Highest at 49.57 %

PRE-TAX PROFIT(Q)

Highest at USD 90.35 MM

NET PROFIT(Q)

Highest at USD 59.95 MM

EPS(Q)

Highest at USD 0.17

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS

Here's what is working for Sotera Health Co.

Operating Cash Flow
Highest at USD 267.94 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Interest Coverage Ratio
Highest at 386.4
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Profit
At USD 59.95 MM has Grown at 146.87%
over average net sales of the previous four periods of USD 24.29 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales
Highest at USD 311.31 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 154.32 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 49.57 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 90.35 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit
At USD 90.35 MM has Grown at 70.98%
over average net sales of the previous four periods of USD 52.84 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 59.95 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.17
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Cash and Eqv
Highest at USD 635.3 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at 359.03 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -12.51% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales